Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
The Swedish Dental and Pharmaceutical Benefits Agency, TLV has decided to fully reimburse Dymista. Dymista is a prescription drug for the treatment of seasonal and perennial allergic rhinitis and studies have shown a more rapid and more complete symptom relief than Fluticasone. Dymista was approved in Europe in 2013.
Help employers find you! Check out all the jobs and post your resume.
